Suchergebnisse - "Al-Harbi, Mohammad Matar"

PubPharm (13)

1

Effect of Apremilast on LPS-induced immunomodulation and inflammation via activation of Nrf2/HO-1 pathways in rat lungs

enthalten in: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society | 2023

von Al-Harbi, N. | Imam, F. | Al-Harbi, M. | +7

2

Corrigendum to "Protective effect of Apremilast against LPS-induced acute lung injury via modulation of oxidative stress and inflammation" [Saudi J. Biol. Sci. 29(5) (2022) 3414-3424

enthalten in: Saudi journal of biological sciences | 2022

von Al-Harbi, N. | Imam, F. | Al-Harbi, M. | +10

ErratumFor: Saudi J Biol Sci. 2022 May;29(5):3414-3424. - PMID 35844406

3

Protective effect of Apremilast against LPS-induced acute lung injury via modulation of oxidative stress and inflammation

enthalten in: Saudi journal of biological sciences | 2022

von Al-Harbi, N. | Imam, F. | Al-Harbi, M. | +10

ErratumIn: Saudi J Biol Sci. 2022 Jun;29(6):103279. - PMID 35503423

4

Corrigendum to "Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways" [Pharmacol. Rep. 70 (2018) 993-1000

enthalten in: Pharmacological reports : PR | 2019

von Imam, F. | Al-Harbi, N. | Al-Harbi, M. | +10

ErratumFor: Pharmacol Rep. 2018 Oct;70(5):993-1000. - PMID 30118964

5

Erratum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-KB signaling pathways”

enthalten in: Pharmacological reports | 2019

von Imam, F. | Al-Harbi, N. | Al-Harbi, M. | +10

6

Erratum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-KB signaling pathways”

enthalten in: Pharmacological reports | 2019

von Imam, F. | Al-Harbi, N. | Al-Harbi, M. | +10

7

Erratum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-KB signaling pathways”

enthalten in: Pharmacological reports | 2019

von Imam, F. | Al-Harbi, N. | Al-Harbi, M. | +10

8

Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways

enthalten in: Pharmacological reports : PR | 2018

von Imam, F. | Al-Harbi, N. | Al-Harbi, M. | +10

ErratumIn: Pharmacol Rep. 2019 Dec;71(6):1227. - PMID 31669887

9

Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways

enthalten in: Pharmacological reports | 2018

von Imam, F. | Al-Harbi, N. | Al-Harbi, M. | +10

10

Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways

enthalten in: Pharmacological reports | 2018

von Imam, F. | Al-Harbi, N. | Al-Harbi, M. | +10